NGen will invest at least $50 million in Supercluster funding to support companies as they rapidly respond to the COVID-19 crisis by building a Canadian supply of essential equipment, products and therapeutics.
The following resources are being compiled to help medical-licensed manufacturers provide a high-quality, rapid response to the COVID-19 pandemic. Documentation will be added as it becomes available. NGen provides this information for convenience only and has not been involved in certification or approval. All production should be confirmed with appropriate government authorities.
Funding Available
Up to $5,000,000
